heart valve prosthesis implantation

Summary

Summary: Surgical insertion of synthetic material to repair injured or diseased heart valves.

Top Publications

  1. ncbi Prosthesis-related complications: first-year annual rates
    W R Eric Jamieson
    University of British Columbia, Vancouver, Canada
    J Heart Valve Dis 11:758-63. 2002
  2. ncbi Clinical evaluation of the carbomedics prosthesis: experience at providence health system in Portland
    Kenji Minakata
    Providence Health System, Portland, Oregon 97225, USA
    J Heart Valve Dis 11:844-50. 2002
  3. ncbi Bivalvular mechanical mitral-aortic valve replacement in 254 patients: long-term results--a 22-year follow-up
    Jean Paul Remadi
    Cardiovascular Surgery Unit, G and R Läennec University Hospital, Nantes, France
    Ann Thorac Surg 76:487-92. 2003
  4. ncbi Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study
    Johanna J M Takkenberg
    Department of Cardio Thoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
    Eur J Cardiothorac Surg 31:851-9. 2007
  5. ncbi The year in valvular heart disease
    Shahbudin H Rahimtoola
    Griffith Center, Division of Cardiovascular Medicine, Department of Medicine, LAC+USC Medical Center, Keck School of Medicine at University of Southern California, Los Angeles, CA 90033, USA
    J Am Coll Cardiol 51:760-70. 2008
  6. ncbi Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve
    Martyn Thomas
    St Thomas Hospital, London, UK
    Circulation 122:62-9. 2010
  7. ncbi Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience
    Josep Rodes-Cabau
    Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada
    J Am Coll Cardiol 55:1080-90. 2010
  8. ncbi Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval
    Nicolo Piazza
    Thoraxcenter, Rotterdam, The Netherlands
    EuroIntervention 4:242-9. 2008
  9. ncbi Observed and relative survival after aortic valve replacement
    P Kvidal
    Department of Cardiology, University Hospital, Uppsala, Sweden
    J Am Coll Cardiol 35:747-56. 2000
  10. ncbi Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
    Alec Vahanian
    Service de cardiologie, , Paris, France
    Eur Heart J 28:230-68. 2007

Detail Information

Publications227 found, 100 shown here

  1. ncbi Prosthesis-related complications: first-year annual rates
    W R Eric Jamieson
    University of British Columbia, Vancouver, Canada
    J Heart Valve Dis 11:758-63. 2002
    ..The aim of this report was to provide an additional method for consideration by regulatory authorities in determination of the standards of performance for pre-market approval of new prosthetic valves for heart valve replacement surgery...
  2. ncbi Clinical evaluation of the carbomedics prosthesis: experience at providence health system in Portland
    Kenji Minakata
    Providence Health System, Portland, Oregon 97225, USA
    J Heart Valve Dis 11:844-50. 2002
    ..CONCLUSION: Early and intermediate-term follow up of the CarboMedics prosthesis indicates that the clinical performance of this valve is satisfactory, and results are comparable with those obtained for other mechanical valves...
  3. ncbi Bivalvular mechanical mitral-aortic valve replacement in 254 patients: long-term results--a 22-year follow-up
    Jean Paul Remadi
    Cardiovascular Surgery Unit, G and R Läennec University Hospital, Nantes, France
    Ann Thorac Surg 76:487-92. 2003
    ..The follow-up was 22 years (1979 to 2001). The last patient was operated on 12 years before the end of the follow-up...
  4. ncbi Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study
    Johanna J M Takkenberg
    Department of Cardio Thoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
    Eur J Cardiothorac Surg 31:851-9. 2007
    ..In this light we analyzed our ongoing prospective allograft AVR cohort and compared allograft durability with other biological aortic valve substitutes...
  5. ncbi The year in valvular heart disease
    Shahbudin H Rahimtoola
    Griffith Center, Division of Cardiovascular Medicine, Department of Medicine, LAC+USC Medical Center, Keck School of Medicine at University of Southern California, Los Angeles, CA 90033, USA
    J Am Coll Cardiol 51:760-70. 2008
  6. ncbi Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve
    Martyn Thomas
    St Thomas Hospital, London, UK
    Circulation 122:62-9. 2010
    ..The Edwards SAPIEN valve was approved for transcatheter aortic valve implantation transfemoral delivery in the European Union in November 2007 and for transapical delivery in January 2008...
  7. ncbi Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience
    Josep Rodes-Cabau
    Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada
    J Am Coll Cardiol 55:1080-90. 2010
    ....
  8. ncbi Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval
    Nicolo Piazza
    Thoraxcenter, Rotterdam, The Netherlands
    EuroIntervention 4:242-9. 2008
    ..To describe the procedural performance and 30-day outcomes following implantation using the 18 Fr CoreValve Revalving System (CRS) as part of the multicentre, expanded evaluation registry, 1-year after obtaining CE mark approval...
  9. ncbi Observed and relative survival after aortic valve replacement
    P Kvidal
    Department of Cardiology, University Hospital, Uppsala, Sweden
    J Am Coll Cardiol 35:747-56. 2000
    ..We sought to evaluate the effects of a number of factors that can potentially determine the optimal time for aortic valve replacement (AVR) and the observed and relative survival after the operation...
  10. ncbi Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
    Alec Vahanian
    Service de cardiologie, , Paris, France
    Eur Heart J 28:230-68. 2007
  11. ncbi Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percu
    Alec Vahanian
    Hopital Bichat, Paris, France
    Eur Heart J 29:1463-70. 2008
    ..To critically review the available transcatheter aortic valve implantation techniques and their results, as well as propose recommendations for their use and development...
  12. ncbi Percutaneous aortic valve implantation retrograde from the femoral artery
    John G Webb
    Division of Cardiology, St Paul s Hospital, Vancouver, British Columbia, Canada
    Circulation 113:842-50. 2006
    ..Retrograde prosthetic aortic valve implantation via the femoral artery has potential advantages. Percutaneous prosthetic aortic valve implantation via the femoral arterial approach is described and the initial experience reported...
  13. ncbi Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description
    Alain Cribier
    Department of Cardiology, Charles Nicolle Hospital, University of Rouen, Rouen, France
    Circulation 106:3006-8. 2002
    ..Valve replacement had been declined for this patient, and balloon valvuloplasty had been performed with nonsustained results...
  14. ncbi Guidelines for reporting mortality and morbidity after cardiac valve interventions
    Cary W Akins
    The American Association for Thoracic Surgery, Beverly, Massachusetts, USA
    Ann Thorac Surg 85:1490-5. 2008
  15. ncbi Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience
    Nicolas M Van Mieghem
    Department of Cardiology, Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands
    EuroIntervention 5:673-9. 2010
    ..Access site complications, therefore, can be a concern. The aim of this study is to present the 30-day incidence of major and minor vascular complications in patients treated with the third generation 18 Fr Medtronic CoreValve System...
  16. ncbi Transcatheter aortic valve implantation: first results from a multi-centre real-world registry
    Ralf Zahn
    Abteilung fur Kardiologie, Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
    Eur Heart J 32:198-204. 2011
    ..We report the first results of the prospective multi-centre German Transcatheter Aortic Valve Interventions-Registry...
  17. ncbi Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system
    Eberhard Grube
    Departments of Cardiology, Cardiac Surgery, and Anaesthesiology, HELIOS Heart Center Siegburg, Ringstrasse 49, Siegburg, Germany
    Circ Cardiovasc Interv 1:167-75. 2008
    ..This study was intended to provide a summary of the development and current safety and efficacy status of the self-expanding CoreValve Revalving prosthesis...
  18. ncbi Unexpected complications of transapical aortic valve implantation
    Nawwar Al-Attar
    Department of Cardiovascular Surgery, Bichat Claude Bernard Hospital, Paris, France
    Ann Thorac Surg 88:90-4. 2009
    ..However, specific problems of this new procedure are not well-described. Unexpected complications due to the procedure and their management are reported...
  19. ncbi Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome
    Gregory Ducrocq
    Department of Cardiology, Bichat Claude Bernard Hospital, Paris, France
    EuroIntervention 5:666-72. 2010
    ..Vascular complications remain the main limitation of transfemoral aortic valve implantation. Based on a single-centre experience, we aim to detail the type, management and impact of those vascular complications...
  20. ncbi Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis
    Dominique Himbert
    Department of Cardiology, Assistance Publique Hopitaux de Paris, Bichat Claude Bernard Hospital, Paris, France
    J Am Coll Cardiol 54:303-11. 2009
    ..We sought to describe the results of a strategy offering either transfemoral or transapical aortic valve implantation in high-risk patients with severe aortic stenosis...
  21. ncbi Treatment of destructive aortic valve endocarditis with the Freestyle Aortic Root Bioprosthesis
    Ludwig C Müller
    Department of Cardiac Surgery, University of Innsbruck, Innsbruck, Austria
    Ann Thorac Surg 75:453-6. 2003
    ..Homograft aortic roots are the conduits of choice, but because they are not available in all cases, alternative conduits are needed...
  22. ncbi Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy
    T Walther
    University Leipzig, Heartcenter, Department of Cardiac Surgery, Leipzig, Germany
    Circulation 100:II6-10. 1999
    ..The aim of this prospectively randomized study was to evaluate left ventricular hypertrophy and its regression after stentless versus conventional biological aortic valve replacement...
  23. ncbi Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes
    John G Webb
    St Paul s Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
    Circulation 119:3009-16. 2009
    ..Transcatheter aortic valve implantation is an alternative to open heart surgery in patients with aortic stenosis. However, long-term data on a programmatic approach to aortic valve implantation remain sparse...
  24. ncbi Transapical minimally invasive aortic valve implantation; the initial 50 patients
    Thomas Walther
    University Leipzig, Heartcenter, Department of Cardiac Surgery, Leipzig, Germany
    Eur J Cardiothorac Surg 33:983-8. 2008
    ..To evaluate the feasibility of minimally invasive transapical beating heart aortic valve implantation (TAP-AVI) for high-risk patients with aortic stenosis...
  25. ncbi Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair
    A L Knauth
    Department of Cardiology, Children s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA
    Heart 94:211-6. 2008
    ..Factors associated with impaired clinical status in a cross-sectional study of patients with repaired tetralogy of Fallot (TOF) have been reported previously...
  26. ncbi Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement
    Ramdas G Pai
    Division of Cardiology, Loma Linda University Medical Center, Loma Linda, California, USA
    Ann Thorac Surg 82:2116-22. 2006
    ..Survival of the asymptomatic unoperated or nonoperable patients may potentially be improved by the use of beta blockers and statins...
  27. ncbi Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis
    Padmini Varadarajan
    Division of Cardiology, Loma Linda University Medical Center, Loma Linda, California, USA
    Ann Thorac Surg 82:2111-5. 2006
    ..Concomitant pharmacotherapy had no impact on survival. CONCLUSIONS: Conservatively treated patients with severe AS have a grave prognosis, and it is worse in the presence of advanced age, LV dysfunction, heart failure, and renal failure...
  28. ncbi Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplin
    Todd K Rosengart
    State University of New York Stony Brook, USA
    Circulation 117:1750-67. 2008
    ....
  29. ncbi Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients
    Augusto D'Onofrio
    Division of Cardiac Surgery, San Bortolo Hospital, Vicenza, Italy
    J Thorac Cardiovasc Surg 134:491-5. 2007
    ..The aim of this single-center retrospective study was to assess midterm clinical and hemodynamic results of aortic valve replacement with the Sorin Pericarbon Freedom stentless bioprosthesis...
  30. ncbi First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up
    Carlos E Ruiz
    Department of Cardiac and Vascular Interventional Services, Lenox Hill Heart and Vascular Institute of New York, New York, USA
    Catheter Cardiovasc Interv 72:143-8. 2008
    ..This study was conducted to report the clinical, hemodynamic, and iconographic outcomes of the longest survivor of the global CoreValve experience...
  31. ncbi Cerebrovascular events after stentless aortic valve replacement during a 9-year follow-up period
    Helmut Gulbins
    Department of Cardiac Surgery, Heart Institute Lahr, Institute of Cardiovascular Medicine, University Witten Herdecke, Hamburg, Germany
    Ann Thorac Surg 86:769-73. 2008
    ..The purpose of this study was to evaluate the incidence of cerebrovascular events during long-term follow-up after stentless aortic valve replacement...
  32. ncbi Long-term results after aortic valve replacement with the Bravo 400 stentless xenograft
    GianLuca Polvani
    Department of Cardiac Surgery and Cardiology, University of Milan, Centro Cardiologico Monzino IRCCS, Milan, Italy
    Ann Thorac Surg 80:495-501. 2005
    ..Left ventricular mass index at 10-year follow-up was 68.5% of the preoperative value. CONCLUSIONS: The Bravo Cardiovascular Model 400 stentless xenograft has provided good clinical and hemodynamic results up until 11 years of follow-up...
  33. ncbi Stentless versus conventional xenograft aortic valve replacement: midterm results of a prospectively randomized trial
    Sven Lehmann
    Department of Cardiac Surgery, Heartcenter, University of Leipzig, Leipzig, Germany
    Ann Thorac Surg 84:467-72. 2007
    ..The purpose of this study was to analyze the 5- to 8-year clinical results after prospectively randomized stentless versus conventional aortic valve replacement...
  34. ncbi Implantation of two self-expanding aortic bioprosthetic valves during the same procedure-Insights into valve-in-valve implantation ("Russian doll concept")
    Nicolo Piazza
    Interventional Cardiology Department, Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 73:530-9. 2009
    ..We discuss also the potential valve of on-line quantitative angiography for assessing the depth of valve implantation and the need to implant a second valve...
  35. ncbi Aortic valve replacement with Toronto SPV bioprosthesis: optimal patient survival but suboptimal valve durability
    Tirone E David
    Peter Munk Cardiac Centre at Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada
    J Thorac Cardiovasc Surg 135:19-24. 2008
    ..Our objective was to examine the clinical outcomes of aortic valve replacement with the Toronto SPV bioprosthesis at 12 years...
  36. ncbi Patient-specific MRI-based 3D FSI RV/LV/patch models for pulmonary valve replacement surgery and patch optimization
    Dalin Tang
    Mathematical Sciences Department, Worcester Polytechnic Institute, Worcester, MA 01609, USA
    J Biomech Eng 130:041010. 2008
    ..More patient studies are needed to validate our findings...
  37. ncbi Randomized comparison of stentless versus stented valves for aortic stenosis: effects on left ventricular mass
    Diego Perez De Arenaza
    Royal Brompton and Harefield NHS Trust, London, UK
    Circulation 112:2696-702. 2005
    ....
  38. ncbi Early insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular dimensions
    Hitendu Hasmukhlal Dave
    Division of Congenital Cardiac Surgery, University Children s Hospital Zurich, Zurich, Switzerland
    Ann Thorac Surg 80:1615-20; discussion 1620-1. 2005
    ..This study assesses the results of early insertion of a pulmonary valve for chronic pulmonary regurgitation based on right ventricular volume measurements...
  39. ncbi Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis
    Lutz Buellesfeld
    Department of Cardiology, HELIOS Heart Center Siegburg, Siegburg, Germany
    Catheter Cardiovasc Interv 71:579-84. 2008
    ..We implanted this prosthesis in a 93-year old patient presenting with severe symptomatic aortic stenosis (valve area: 0.6 cm(2)). Surgical valve replacement had been declined due to comorbidities...
  40. ncbi Surgical treatment of active aortic endocarditis: homografts are not the cornerstone of outcome
    Jean Francois Avierinos
    Departement de Cardiologie, Hopital Timone, Marseille, France
    Ann Thorac Surg 84:1935-42. 2007
    ..Surgical treatment of active aortic infective endocarditis is challenging, and the type of prosthesis to be implanted during the active phase remains controversial...
  41. ncbi Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors
    Sam Dawkins
    Wessex Cardiac Unit, Southampton University Hospital, Southampton, United Kingdom
    Ann Thorac Surg 85:108-12. 2008
    ..We sought to identify the contemporary incidence and predictors for early postoperative PPM in patients undergoing isolated aortic valve replacement...
  42. ncbi Effects of pulmonary valve replacement on QRS duration and right ventricular cavity size late after repair of right ventricular outflow tract obstruction
    Abdul R Doughan
    Adult Congenital Cardiac Program, Emory University Hospital School of Medicine, Atlanta, Georgia 30303, USA
    Am J Cardiol 95:1511-4. 2005
    ..93, p <0.0001) as well as after (r = 0.82, p <0.001) PVR. In patients with pulmonary regurgitation late after repair of RV outflow tract obstruction, PVR reduces maximal QRS duration with a concomitant decrease in RV volumes...
  43. ncbi New anatomically oriented transapical aortic valve implantation
    Volkmar Falk
    Klinik fur Herzchirurgie, Universitat Leipzig, Herzzentrum, Leipzig, Germany
    Ann Thorac Surg 87:925-6. 2009
    ..Here we report implantation of this new valve in a patient. The valve demonstrated excellent function with a low transvalvular gradient...
  44. ncbi Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis
    Hasan Jilaihawi
    Glenfield Hospital, Leicester, United Kingdom
    Am Heart J 157:860-6. 2009
    ..We hypothesized that the need for PPM after CoreValve (Corevalve Inc, Irvine, CA) can be predicted with a combination of baseline variables...
  45. ncbi Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography
    A Ionescu
    University of Wales College of Medicine, Cardiff, UK
    Heart 89:1316-21. 2003
    ..To assess the prevalence, mechanisms, and significance of paraprosthetic regurgitation detected incidentally by transoesophageal echocardiography (TOE) in patients after heart valve replacement...
  46. ncbi Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population
    Didier Tchetche
    Clinique Pasteur, Toulouse, France
    EuroIntervention 5:659-65. 2010
    ..We report 30-day data from a mixed population of patients treated with either Medtronic CoreValve (MCV) or Edwards SAPIEN (ES) valves...
  47. ncbi Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis
    Carl J Schultz
    Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 54:911-8. 2009
    ..Using multislice computed tomography (MSCT), we sought to evaluate the geometry and apposition of the CoreValve ReValving System (CRS, Medtronic, Luxembourgh, Luxembourgh) in patients with aortic stenosis...
  48. ncbi Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study
    Philipp Kahlert
    West German Heart Center Essen, Department of Cardiology, University Duisburg Essen, Hufelandstrasse 55, 45122 Essen, Germany
    Circulation 121:870-8. 2010
    ..The rate of clinically silent cerebral ischemia is unknown but may be even higher...
  49. ncbi Transapical transcatheter aortic valve implantation: follow-up to 3 years
    Jian Ye
    Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    J Thorac Cardiovasc Surg 139:1107-13, 1113.e1. 2010
    ..We now report clinical and echocardiographic outcomes of transapical aortic valve implantation in 71 patients...
  50. ncbi Transcatheter aortic valve prosthesis surgically replaced 4 months after implantation
    Hans Gustav Thyregod
    Department of Cardiothoracic Surgery, The Heart Centre, Rigshospitalet, University of Copenhagen, DK 2100, Copenhagen, Denmark
    Eur J Cardiothorac Surg 37:494-6. 2010
    ..We report the first case of surgical valve replacement in a patient with a dysfunctional transcatheter-implanted aortic valve prosthesis 4 months after implantation...
  51. ncbi Effect of altering pathologic right ventricular loading conditions by percutaneous pulmonary valve implantation on exercise capacity
    Philipp Lurz
    Cardiovascular Unit, UCL Institute of Child Health and Cardiorespiratory Unit, Great Ormond Street Hospital for Children, London, UK
    Am J Cardiol 105:721-6. 2010
    ..A reduction in the RVOT gradient, even small gradients, was the only independent predictor of improved peak oxygen uptake in both patient groups, irrespective of improved pulmonary valve competence...
  52. ncbi Aortic valve replacement in patients with impaired ventricular function
    Ram Sharony
    Division of Cardiothoracic Surgery, Department of Surgery, New York University School of Medicine, New York, New York, USA
    Ann Thorac Surg 75:1808-14. 2003
    ..The type of valvular pathophysiology does not significantly affect mortality...
  53. ncbi Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging
    Alexander Ghanem
    Department of Medicine Cardiology, University of Bonn, Bonn, Germany
    J Am Coll Cardiol 55:1427-32. 2010
    ..The aim of this study was prospective investigation of silent and clinically apparent cerebral embolic events and neurological impairment after transfemoral aortic valve implantation (TAVI)...
  54. ncbi Percutaneous transcatheter aortic valve replacement: first transapical implant in Asia
    V T T Chao
    Department of Cardiothoracic Surgery, National Heart Centre, 17 Third Hospital Avenue, Singapore 168752
    Singapore Med J 51:69-72. 2010
    ..A 79-year-old Chinese woman with symptomatic severe AS and peripheral arterial disease, who was at high surgical risk, was successfully treated, and had good functional and haemodynamic results at the three-month follow-up...
  55. ncbi Pulmonary valve replacement after tetralogy of Fallot repair in preadolescent patients
    C Wesley Lindsey
    Sibley Heart Center Cardiology, Department of Pediatrics, Division of Pediatric Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
    Ann Thorac Surg 89:147-51. 2010
    ..Most studies addressing the role of PVR have examined older adolescents or adults. Less is known about the potential benefits of PVR in preadolescents with TOF and significant right ventricular dilatation...
  56. ncbi Unexpected left ventricular free-wall rupture following an aortic catheter-valve implantation
    Enrico Ferrari
    Department of Cardio Vascular Surgery, University Hospital of Lausanne CHUV, Lausanne, Switzerland
    Eur J Cardiothorac Surg 37:242-4. 2010
    ..To the best of our knowledge, this is the first described case of a left ventricular free-wall rupture occurring after an otherwise non-complicated standard catheter-based aortic valve replacement...
  57. ncbi Quality of life assessment after percutaneous aortic valve implantation
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Via Citelli 6, Catania, Italy
    Eur Heart J 30:1790-6. 2009
    ..To assess the NYHA class and the quality of life (QoL) scores after percutaneous aortic valve implantation (PAVI) with the 18-Fr CoreValve prosthesis...
  58. ncbi Atrioventricular block after transcatheter balloon expandable aortic valve implantation
    Ajay Sinhal
    Heart Centre, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    JACC Cardiovasc Interv 1:305-9. 2008
    ..Transcatheter aortic valve replacement (AVR) is a promising approach to aortic valve disease. The implications of this new therapy are not entirely known. We describe the potential for the development of new atrioventricular (AV) block...
  59. ncbi Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation
    William C Roberts
    Baylor Heart and Vascular Institute and the Department of Pathology, Baylor University Medical Center, 3500 Gaston Ave, Dallas, TX 75246, USA
    Circulation 111:920-5. 2005
    ....
  60. ncbi Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve
    Nicolo Piazza
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 1:310-6. 2008
    ..In this retrospective study, we examined the incidence of post-procedural conduction abnormalities and the need for pacing in patients undergoing percutaneous implantation of the aortic valve...
  61. ncbi An integrated pericardial valved stent special for percutaneous tricuspid implantation: an animal feasibility study
    Yuan Bai
    Department of Cardiology, Changhai Hospital, The Second Military Medical University, Shanghai, PR China
    J Surg Res 160:215-21. 2010
    ..To broaden the indications of percutaneous approach to atrioventricular valves replacement, we developed a novel valved stent and evaluated the feasibility and safety of percutaneous implantation of the device in the tricuspid position...
  62. ncbi The subcoronary Toronto stentless versus supra-annular Perimount stented replacement aortic valve: early clinical and hemodynamic results of a randomized comparison in 160 patients
    John B Chambers
    Valve Study Group, St Thomas Hospital, London, United Kingdom
    J Thorac Cardiovasc Surg 131:878-2. 2006
    ..The aim of this study was to compare early postoperative hemodynamic function and clinical events in a randomized, prospective series of 160 stentless and stented biological replacement aortic valves...
  63. ncbi Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis
    Matthieu Godin
    Department of Cardiology, Rouen University Hospital and INSERM U, University of Rouen, France
    Am J Cardiol 106:707-12. 2010
    ..The physical properties of this prosthesis may explain this observation...
  64. ncbi Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of fallot
    Eddie Wai yin Cheung
    Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, People s Republic of China
    Am J Cardiol 106:552-7. 2010
    ..In conclusion, surgical PVR in patients after tetralogy of Fallot repair has been associated with low early and late mortality and significant decreases in RV volumes but no changes in the RV ejection fraction or QRS duration...
  65. ncbi The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study
    Dimitri Kalavrouziotis
    Department of Surgery, Division of Cardiac Surgery, Queen Elizabeth II Health Sciences Centre, Dalhousie University, 1796 Summer Street, Room 2269, Halifax, Nova Scotia, B3H 3A7, Canada
    J Cardiothorac Surg 4:32. 2009
    ..The objective of this study was to determine the accuracy of the EuroSCORE in predicting mortality following aortic valve replacement (AVR)...
  66. ncbi Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation
    Marcos Gutierrez
    Quebec Heart and Lung Institute, Quebec, Quebec G1V 4G5, Canada
    Am Heart J 158:302-8. 2009
    ..The objective of our study was to determine the incidence, type, and timing of ECG changes associated with TAVI...
  67. ncbi Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence
    Delphine Detaint
    Cardiology Department, Hopital Bichat, Paris, France
    JACC Cardiovasc Interv 2:821-7. 2009
    ..The aim of this study was to assess prosthesis/annulus discongruence and its impact on the occurrence of significant aortic regurgitation (AR) immediately after transcatheter aortic valve implantation (TAVI)...
  68. ncbi An expanded polytetrafluoroethylene-autologous aortic hybrid valve for right ventricular outflow tract reconstruction in the Ross procedure
    Takako Miyazaki
    Department of Pediatric Cardiovascular Surgery, Children s Research Hospital, Kyoto Prefectural University of Medicine, 465 Kajii cho, Kawaramachi, Hirokoji, Kamigyo ku, Kyoto, 602 8566, Japan
    Interact Cardiovasc Thorac Surg 6:163-6. 2007
    ..Given its theoretical growth potential, we speculate that this valve could be a good choice for RVOT reconstruction in the Ross procedure, especially for young children...
  69. ncbi One year hemodynamic performance of the Perimount Magna pericardial xenograft and the Medtronic Mosaic bioprosthesis in the aortic position: a prospective randomized study
    María José Dalmau
    Department of Cardiac Surgery, Salamanca University Hospital, Paseo de San Vicente 58 182, 37007 Salamanca, Spain
    Interact Cardiovasc Thorac Surg 6:345-9. 2007
    ..8% (MM) vs. 6.9% (EPM) of the patients (P=0.01). When the same AAD is taken as a reference, the EPM-valve was hemodynamically superior to the MM-bioprosthesis. The EPM-prosthesis significantly reduced the incidence of PPM...
  70. ncbi Unicuspid aortic valve mimicking quadricuspid valve
    Takeyoshi Ota
    Department of Cardiovascular Surgery, Kobe University Graduate School of Medicine, Kobe 650 0017, Japan
    Heart Vessels 22:352-4. 2007
    ..Unicuspid aortic valve is a rare congenital cardiac abnormality, leading to aortic stenosis or regurgitation. We report the case of a 55-year-old man with severe aortic regurgitation caused by a unicuspid valve mimicking quadricuspid valve...
  71. ncbi Aortic valve replacement with mitral valve repair compared with combined aortic and mitral valve replacement
    Sachin Talwar
    Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India
    Ann Thorac Surg 84:1219-25. 2007
    ..Double valve replacement is associated with reduced long-term survival. This study investigates aortic valve replacement with mitral valve repair as an alternative to double valve replacement in patients with rheumatic heart disease (RHD)...
  72. ncbi Mid-term results after Epic xenograft implantation for aortic, mitral, and double valve replacement
    Sven Lehmann
    University Leipzig, Heartcenter, Department of Cardiac Surgery, Leipzig, Germany
    J Heart Valve Dis 16:641-8; discussion 648. 2007
    ..The study aim was to evaluate the mid-term results after implantation of the stented porcine xenograft (Epic valve with Linx anticalcification treatment) in elderly patients...
  73. ncbi [Surgical management of aortic valve stenosis]
    Georg Kleikamp
    Klinik für Thorax und Kardiovaskularchirurgie, Herz und Diabeteszentrum NRW, Universitatsklinik der Ruhr Universitat Bochum, Georgstrasse 11, 32545 Bad Oeynhausen
    Herz 31:670-5. 2006
    ..All newly developed procedures for the treatment of aortic stenosis therefore will have to prove their superiority in future...
  74. ncbi Long-term results of aortic valve replacement with a small St. Jude medical valve in Japanese patients
    Kazuhiro Yoshikawa
    Department of Surgery, Kurume University School of Medicine, Kurume, Japan
    Ann Thorac Surg 85:1303-8. 2008
    ..This study evaluated the long-term results after aortic valve replacement with a small valve from St. Jude Medical (St. Paul, MN)...
  75. ncbi [Selection of prosthetic heart valves for adult patients by age]
    Kazuhiro Hashimoto
    Department of Cardiovascular Surgery, Jikei University School of Medicine, Tokyo, Japan
    Nihon Geka Gakkai Zasshi 108:69-72. 2007
    ....
  76. ncbi The experience with porcine bioprostheses at Padua University
    Gino Gerosa
    Department of Cardiovascular Surgery, University of Padua Medical School, Padua, Italy
    J Heart Valve Dis 13:S44-8. 2004
  77. ncbi Tear in mitral anterior leaflet as a complication of Manouguian's procedure in a woman with an aortic valve prosthesis
    Alev Arat-Ozkan
    Istanbul University, Institute of Cardiology, Istanbul, Turkey
    J Heart Valve Dis 13:630-1. 2004
    ..The case is reported of a woman with aortic valve replacement and annular enlargement who had mitral regurgitation due to a tear in the anterior mitral leaflet as a complication of Manouguian's annulus enlargement...
  78. ncbi Evaluation of stentless kangaroo aortic valves in the mitral position of juvenile sheep
    Andrew J Hodge
    Department of Cardiothoracic Surgery, Fremantle Hospital, Western Australia
    J Heart Valve Dis 13:681-8. 2004
    ..The study aim was to assess the feasibility of a mitral model for stentless valves and to evaluate the calcification behavior of stentless glutaraldehyde-preserved kangaroo heart valves in the mitral position of a sheep model...
  79. ncbi Mid-term follow-up in patients with Biocor porcine bioprostheses
    Tomaso Bottio
    Department of Cardiovascular Surgery, University of Padua Medical School, Padua, Italy
    Cardiovasc Surg 10:238-44. 2002
    ..We reviewed survival and prosthetic complications of Biocor porcine bioprostheses implanted in mitral, aortic and mitro-aortic position...
  80. ncbi A retrospective comparative study of aortic valve replacement with St. Jude medical and medtronic-hall prostheses: a 20-year follow-up study
    Vesa Anttila
    Department of Cardio-thoracic and Vascular Surgery, University of Oulu, Finland
    Scand Cardiovasc J 36:53-9. 2002
    ..However, these results suggest a reappraisal for further comparative studies with such an extended follow-up...
  81. ncbi Transvalvular velocities after full aortic root replacement: results from a prospective randomized trial between the homograft and the Medtronic Freestyle bioprosthesis
    Giovanni Melina
    Academic Department of Cardiothoracic Surgery, NHLI, The Royal Brompton and Harefield NHS Trust, London, UK
    J Heart Valve Dis 11:54-8; discussion 58-9. 2002
    ....
  82. ncbi Mitral valve repair with aortic valve replacement in rheumatic heart disease
    Huynh Quang Tri Ho
    Heart Institute, Ho Chi Minh City, Vietnam
    Asian Cardiovasc Thorac Ann 12:341-5. 2004
    ..Therefore, whenever feasible, mitral valve repair should be attempted in patients with rheumatic heart disease who need concomitant aortic valve replacement...
  83. ncbi Re-do aortic valve replacement: does a previous homograft influence the operative outcome?
    Pankaj Kumar
    Department of Cardiac Surgery, Royal Brompton Hospital, London, UK
    J Heart Valve Dis 13:904-12; discussion 912-3. 2004
    ..A review is presented of the authors' experience of redo-aortic valve replacement (re-do AVR) examining factors which affect, and whether a previous aortic homograft replacement influences, operative outcome...
  84. ncbi The aortic Elan stentless aortic valve: excellent hemodynamics and ease of implantation
    M Flynn
    Department of Cardiothoracic Surgery and Clinical Research Initiative in Heart Failure, Western Infirmary, Glasgow, UK
    Semin Thorac Cardiovasc Surg 13:48-54. 2001
    ..Ease of implantation is evidenced by favorable ischemic times. This valve may offer an option to homograft in acute aortic endocarditis. Long-term results are awaited...
  85. ncbi The year in valvular heart disease
    Shahbudin H Rahimtoola
    Division of Cardiovascular Medicine, Department of Medicine, LAC+USC Medical Center, Keck School of Medicine at the University of Southern California, Los Angeles, California 90033, USA
    J Am Coll Cardiol 45:111-22. 2005
  86. ncbi A rare case of Listeria monocytogenes presenting as prosthetic valve bacterial endocarditis and aortic root abscess
    Amgad N Makaryus
    North Shore University Hospital, Manhasset, New York 11030, USA
    Echocardiography 21:423-7. 2004
    ..We report the case of an 81-year-old man who suffered aortic prosthetic valve listeria endocarditis, and examine the literature regarding this rare manifestation of human listeriosis...
  87. ncbi The Edwards MIRA heart valve prosthesis: a 2-year study
    Rudolf Driever
    Department of Cardiothoracic Surgery, Heart Center, University of Witten Herdecke, Wuppertal, Germany
    J Card Surg 19:226-31. 2004
    ..The purpose of the study was to investigate the clinical performance and postoperative hemodynamic results of the first European patients receiving Edwards MIRA mechanical heart valves...
  88. ncbi Late incidence and determinants of reoperation in patients with prosthetic heart valves
    Marc Ruel
    Division of Cardiac Surgery, University of Ottawa Heart Institute, 40 Ruskin Street, Suite 3403, Ottawa, Ont, Canada K1Y 4W7
    Eur J Cardiothorac Surg 25:364-70. 2004
    ..With a focus on bioprosthetic valves, this study examines risk factors for reoperation in a large patient cohort...
  89. ncbi [Clinical and hemodynamic results of the mosaic bioprosthesis in aortic position]
    F Botzenhardt
    , Germany
    Z Kardiol 92:407-14. 2003
    ..CONCLUSION: The Mosaic bioprosthesis proved to be a reliable and well-functioning device for aortic valve replacement, especially in larger sizes...
  90. ncbi Valved stentless composite graft: clinical outcomes and hemodynamic characteristics
    Paul P Urbanski
    Herz und Gefaess Klinik, Bad Neustadt, Germany
    Ann Thorac Surg 75:467-71. 2003
    ..This study was conducted to evaluate the postoperative hemodynamic characteristics and clinical outcomes after implantation of this device...
  91. ncbi Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement
    Georg Nollert
    Department of Cardiac Surgery, University of Munich, Munich, Germany
    J Thorac Cardiovasc Surg 126:965-8. 2003
    ....
  92. ncbi [Early and subsequent results of operation of trivalvular diseases]
    Bogdan Stefaniak

    Wiad Lek 56:348-52. 2003
    ..Subsequent complications and deaths are most often due to thromboembolic complications, therefore a particular attention should be paid to the anticoagulant treatment in this group of patients...
  93. ncbi [Surgical treatment of aortic valve disease in old age]
    A Schutz
    Herzklinik am Augustinum, LMU Munchen
    MMW Fortschr Med 145:26-8. 2003
    ..For AVR, both mechanical and biological prostheses are available, the latter being regarded as the method of choice in patients aged over 70. The mechanical variant requires life-long anticoagulation therapy with phenprocoumon...
  94. ncbi Reduction of mechanical heart valve thrombosis through a clinical audit
    V Bharat
    Department of Cardiology, Tata Main Hospital, Jamshedpur, India
    J Heart Valve Dis 12:362-9. 2003
    ..Despite successful surgery and regular hospital visits, long-term survival was compromised by anticoagulation-related complications...
  95. ncbi Unexpected durability of Smeloff-Cutter aortic ball valve prosthesis
    Yuji Naito
    Department of Cardiovascular Surgery, Yamanashi Central Hospital, Yamanashi, Japan
    Ann Thorac Surg 75:1633-5. 2003
    ..The patient's aortic ball valve was nearly intact with perivalvular leakage probably causing the aortic regurgitation. Our experience documents longer durability for the Smeloff-Cutter prosthesis than has been reported to date...
  96. ncbi Simultaneous aortic and mitral valve replacement: predictors of adverse outcome
    Kenji Kuwaki
    Department of Thoracic and Cardiovascular Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan
    J Heart Valve Dis 12:169-76. 2003
    ..Mitral bioprosthesis combined with a mechanical aortic valve should be avoided as it increases the risk of reoperation...
  97. ncbi Initial clinical and hemodynamic experience with Edwards MIRA mechanical bileaflet valve
    M De Feo
    Department of Cardio-Thoracic Sciences, 2nd University of Naples, Naples, Italy
    J Cardiovasc Surg (Torino) 44:25-30. 2003
    ..The sewing ring is non-obstructive, compliant with smoother needle penetration. Early clinical results are encouraging, follow-up should be continued...
  98. ncbi Clinical and echocardiographic assessment of pregnant women with valvular heart diseases--maternal and fetal outcome
    Agata Lesniak-Sobelga
    Department of Cardiovascular Diseases, Institute of Cardiology, Jagiellonian University, School of Medicine, ul Pradnicka 80, 31 202 Cracow, Poland
    Int J Cardiol 94:15-23. 2004
    ..The study aimed to compare the outcome of pregnancy in women with valvular heart diseases...
  99. ncbi [Early results of surgical treatment in acquired heart diseases during endocarditis in own material]
    Zbigniew Samitowski
    Klinika Chirurgii Serca, , ,
    Przegl Lek 61:623-6. 2004
    ..If echocardiography shows the cuspids perforations or vegetations, chords tendinous rupture or perivalvular leak, the patients should undergo cardiac surgery as soon as possible, in order to avoid severe embolic complications...
  100. ncbi Twenty-year results of the Hancock II bioprosthesis
    Michael A Borger
    Division of Cardiovascular Surgery, Toronto General Hospital, University Health Network, and Department of Surgery, University of Toronto, Toronto, Ontario, Canada
    J Heart Valve Dis 15:49-55; discussion 55-6. 2006
    ..The Hancock II bioprosthesis (HII) has several design features designed to increase its durability. The study aim was to determine very long-term outcomes for the HII valve in a large patient population...
  101. ncbi Is the St. Jude Medical mechanical valve an appropriate choice for elderly patients?: A long-term retrospective study measuring quality of life
    Kevin D Accola
    Florida Hospital Cardiovascular Institute, Cardiovascular Surgeons, P A, Orlando, Florida 32801, USA
    J Heart Valve Dis 15:57-66; discussion 66. 2006
    ..Quality of life (QOL) considerations are often as important to the patient as longevity. The influence of mechanical valve replacement on QOL in elderly patients has not been well documented...

Research Grants62

  1. Quality Improvement and Outcomes for Strokes After CABG
    DONALD LIKOSKY; Fiscal Year: 2004
    ..abstract_text> ..
  2. Angiogenic tissue engineering to limit post-infarction ventricular remodeling
    Y Joseph Woo; Fiscal Year: 2010
    ....
  3. Angiogenesis and Cardiac Growth as Heart Failure Therapy
    Y Woo; Fiscal Year: 2007
    ..The candidate's institution, sponsor, and chairman provide a uniquely supportive, high-caliber, educationally stimulating environment highly conducive to the achievement of these goals. ..
  4. STICH Trial-Coordinating Center
    Robert Jones; Fiscal Year: 2007
    ..abstract_text> ..
  5. MRI Correlates of Limb Ischemia in PVD
    Thomas Floyd; Fiscal Year: 2007
    ..Finally, we will apply them prospectively to predict graft patency and wound healing after amputation. ..
  6. Testing the Pediatric Cardiac Quality of Life Inventory
    Bradley Marino; Fiscal Year: 2007
    ..S. and the U.K. The proposed didactic and research experiences described will ensure that Dr. Marino becomes an independent physician scientist in the field of pediatric cardiovascular outcomes research. ..
  7. Extracellular Matrix Metabolism in Thoracic Aortic Aneurysm and Dissection
    Scott A LeMaire; Fiscal Year: 2010
    ..With our unique access to a large number of TAAD patients and expertise in cell and animal models, our project is feasible. ..
  8. Outcomes and Costs Associated with Frequency of Physician-Patient Visits on Hemod
    Areef Ishani; Fiscal Year: 2010
    ..Should the trial verify these findings, the current CMS policy should be revised, potentially leading to significant cost savings. ..
  9. Circle of Willis variability and migraine
    BRETT LEE CUCCHIARA; Fiscal Year: 2010
    ..If this hypothesis is confirmed, this could lead to new treatments based on a better understanding of migraine mechanisms and might help identify patients with migraine who are at risk of stroke. ..
  10. Role of Lrp5/Beta-Catenin in Aortic Valve Calcification
    Nalini Rajamannan; Fiscal Year: 2009
    ..The objectives of this proposal are to determine if the Lrp5 receptor is critical in activation of mineralization in aortic valve calcification. ..
  11. Improving Neurologic Outcomes in Diabetics Undergoing Cardiac Surgery
    EDWARD HAL KINCAID; Fiscal Year: 2010
    ....
  12. In Vivo IVUS Image-Based Modeling for Human Coronary Plaque Assessment
    Jie Zheng; Fiscal Year: 2010
    ..Commercialization of the research results is possible with the automation of model construction and data analysis procedures. ..
  13. Translational studies in Heart Failure Gene Therapy
    Charles Bridges; Fiscal Year: 2009
    ..Successful completion of this study may lead to alternatives to heart transplantation and permanent mechanical assist devices in the treatment of end stage heart failure. ..
  14. Stroke & cognition in surgical aortic stenosis
    Thomas Floyd; Fiscal Year: 2009
    ..Finally, the study database will allow us to closely examine the long-term risks for cognitive impairment & dementia from embolic processes during heart surgery.. ..
  15. Role of Lrp5/Beta-Catenin in Aortic Valve Calcification
    Nalini Rajamannan; Fiscal Year: 2009
    ..The objectives of this proposal are to determine if the Lrp5 receptor is critical in activation of mineralization in aortic valve calcification. ..
  16. Role of Lrp5/Beta-Catenin in Aortic Valve Calcification
    Nalini M Rajamannan; Fiscal Year: 2010
    ..The objectives of this proposal are to determine if the Lrp5 receptor is critical in activation of mineralization in aortic valve calcification. ..
  17. Long-term White Matter Changes Resulting from Delirium after Surgery
    James Rudolph; Fiscal Year: 2007
    ..If the hypotheses are confirmed, this will alter our fundamental understanding of delirium as a short-term disorder and future studies can use imaging to prevent, identify, and treat delirium. ..
  18. Grape Seed Extract-Cardiac Impact and Drug Interaction
    Steven Bolling; Fiscal Year: 2005
    ..Considering the increasing use of this botanical extract, improved knowledge of safety and efficacy is imperative. ..
  19. Endocytosis in cardiac myocytes
    Ion Jovin; Fiscal Year: 2005
    ..The discoverry of polypeptides that guide macromolecules to specific cellular organelles or compartments can have profound implications for understanding microbial invasion and for refining gene therapy. ..
  20. Retrograde In Situ Isolated Cardiac Gene Delivery
    Charles Bridges; Fiscal Year: 2004
    ..Further development of this approach may ultimately lead to the development of clinically relevant techniques of therapeutic cardiac gene delivery for the treatment of heart failure of diverse etiologies. ..
  21. PATHOBIOLOGY OF CEREBRAL CAVERNOUS MALFORMATION
    Richard Lifton; Fiscal Year: 2002
    ..They have established a collection of these lesions and have begun developing cell cultures of different cell lines from lesions in order to pursue this aim. ..
  22. Mitral Annular Remodeling for MR Therapy
    Kiyotaka Fukamachi; Fiscal Year: 2005
    ..Therefore, this proposed research program is an important first step in this novel procedure's development as one potential therapeutic option for high-risk CHF patients with functional MR. ..
  23. Stroke & cognition in surgical aortic stenosis
    Thomas Floyd; Fiscal Year: 2007
    ..Finally, the study database will allow us to closely examine the long-term risks for cognitive impairment & dementia from embolic processes during heart surgery.. ..
  24. The long-term consequences of postoperative acute kidney injury
    Areef Ishani; Fiscal Year: 2007
    ..Once the AKI- associated burden of CKD has been precisely estimated and modifiable factors have been identified, clinical trials can be performed that may reduce this disease burden. ..
  25. Cardiothoracic Surgical Network Clinical Center
    Peter Smith; Fiscal Year: 2007
    ..The successful achievement of these aims will be a significant contribution to the Cardiac Surgery Network and the overall care of patients with surgical cardiovascular disease. (End of Abstract) ..
  26. Studies in pig-to-primate cardiac xenotransplantation
    CHRISTOPHER MC GREGOR; Fiscal Year: 2007
    ..In addition, by attempting to reverse rejection episodes with plasmapheresis we will identify the initiating mechanism of graft rejection. This proposal, if successful, lays the groundwork for the clinical application of cardiac XTx. ..
  27. Development and Clinical Testing of CorAide RVAD/BVAD
    Kiyotaka Fukamachi; Fiscal Year: 2007
    ..The successful completion of this program will provide clinicians and patients with a safe and effective option for outpatient mechanical support that allows an excellent quality of life. ..
  28. GENETICS AND GENOMICS OF HUMAN DISEASE
    Richard Lifton; Fiscal Year: 2007
    ..Support is requested for 10 graduate students per year for a five-year period. ..
  29. Matrix Metalloproteinases in Thoracic Aortic Dissection
    SCOTT LEMAIRE; Fiscal Year: 2007
    ....
  30. Cardiac Surgical Ischemia: Biophysical Aspects
    Irvin Krukenkamp; Fiscal Year: 2006
    ..abstract_text> ..